Long‐term persistence of neutralizing SARS‐CoV‐2 antibodies in pets
Nicola Decaro, Andrea Grassi, Eleonora Lorusso, Edward I. Patterson, Alessio Lorusso, Costantina Desario, Enyia R. Anderson, Violetta Iris Vasinioti, Christida E. Wastika, Grant L. Hughes, Fabrizia Valleriani, Barbara Colitti, Dominga Ricci, Domenico Buonavoglia, Sergio Rosati, Nicola Cavaliere, Saverio Paltrinieri, Stefania Lauzi, Gabriella Elia, Canio Buonavoglia
Abstract
We monitored the severe acute respiratory syndrome coronavirus 2 antibody response in seven dogs and two cats by using two multispecies ELISA tests, plaque reduction neutralisation test and virus neutralization. SARS-CoV-2 neutralizing antibodies in pets persisted up to 10 months since the first positive testing, thus replicating observations in COVID-19 human patients.
Topics & Concepts
NeutralizationVirologyNeutralizing antibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CATSAntibodyPlaque reduction neutralization testCoronavirus disease 2019 (COVID-19)Persistence (discontinuity)2019-20 coronavirus outbreakMedicineRespiratory systemCoronavirusVirusBiologyImmunologyInternal medicineOutbreakDiseaseEngineeringGeotechnical engineeringInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesCOVID-19 Clinical Research Studies